New technologies and new concepts to help control and alleviate diabetes

*For medical professionals only

How to rationally apply the new concept of insulin therapy to achieve type 2 diabetes relief and control? This article is clear for you

Professor Li Yanbing The First Affiliated Hospital of Sun Yat-sen University

We have historically thought that type 2 diabetes mellitus (T2DM) is a progressive disease characterized by hyperglycemia that requires long-term glycemic control

Professor Li Yanbing

• Professor, Doctor of Endocrinology, Doctoral Supervisor, Famous Doctor of Sun Yat-sen University
• Director of the Department of Endocrinology, The First Affiliated Hospital of Sun Yat-sen University
• Director of the Key Laboratory of Endocrinology of the Department of Health of Guangdong Province
• Chairman of the Endocrinology Branch of Guangdong Medical Association
• Vice Chairman of diabetes and microcirculation Professional Committee of Chinese Microcirculation Society
• He is a member of the Endocrinology Branch of the Chinese Medical Association and the deputy leader of the Pituitary Group
• Leader of the Chinese Insulin Secretion Research Group
• Guangdong Province national medical leading talent
• Chief expert of the National Major Chronic Disease Key Project
• Guest Editor-in-Chief of J Diabetes Res, Guest Editor of Diabetes Metab Res Rev, Editorial Board Member of Chinese Journal of Diabetes, Editorial Board Member of Chinese Journal of Endocrinology and Metabolism, Associate Editor of Chinese Electronic Journal of Obesity and Metabolic Diseases
• He is the chairman of the third session of the Diabetes Branch of Guangdong Medical Association
• Chairman of the Metabolism and Endocrinology Professional Committee of Guangdong Health Management Society
• He is a member of the Guangdong Provincial Cadre Health Care Expert Group and the chief expert of guangdong Provincial Health Education

References:

[1] Weng J,et al.

Chinese expert consensus on alleviating type 2 diabetes.

Expert consensus on short-term intensive insulin therapy to reverse type 2 diabetes.

[4] Gregg EW,et al.

[5] Ding L,et al.

[6] Retnakaran R,et al.

[7] Weng J,et al.
Lancet.
2008; 371(9626):1753-60.

[8] Wang H et al.
J Clin Endocrinol Metab.
2019; 104(6):2153-2162.

Li Wenhua et al.
Chinese Journal of Diabetes.
2012; 20(11):836-838.

[10] Goldenberg RM,et al.
Diabetes Obes Metab.
2021; 23(11):2572-2581.

[11] Tsimikas A,et al.
Diabetes Care 2022; 45(Suppl.
1):S1–S264.

[12]2021 ADA.
ePoster persentation.
606.

-End-

"This article is only used to provide scientific information to healthcare professionals and does not represent the position of the platform"

For submission/reprint/business cooperation, please contact: pengsanmei@yxj.
org.
cn